T1	Participants 115 156	venous thromboembolism in cancer patients
T2	Participants 437 522	patients on long-term therapy for acute venous thromboembolism who have active cancer
T3	Participants 524 594	Consecutive consenting patients from one center in a multicenter trial
T4	Participants 948 1019	There were 24 patients who had anti-Xa levels measured at weeks 1 and 4
T5	Participants 1021 1152	Two other patients had week 1 measurements performed but died before the week 4 sample was collected due to their underlying cancer
